Jeremy Darling.

Marc L. Schermerhorn, M.D ., Dominique B. Buck, M.D., A.D., Thomas Curran, M.D., John C. McCallum, M.D., Jeremy Darling, B.A., and Bruce E. Landon, M.D., M.B.A.: Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population The use of endovascular repair of stomach aortic aneurysms is increasing. By 2010, endovascular fix accounted for 78 percent of most intact repairs.1,2 Randomized, controlled trials comparing endovascular repair with open restoration generally show a perioperative benefit of endovascular repair over open restoration.3-5 Long-term survival, however, is comparable with the two approaches.6-9 As data on long-term outcomes accumulate, concerns have already been raised about endovascular repair with respect to the increased rate lately failure leading to rupture and higher rates of reintervention.

Approval based just on biased industry dataThe researchers were able to find just 18 peer-reviewed studies assessing the security of any of the 47 crop varieties that had been published prior to the crops in question received regulatory approval. These scholarly research were conducted for only 9 of the 47 crop varieties, meaning that the remaining 38 GMO varieties were approved with zero credible scientific evidence of their safety. Furthermore, many of the 18 research suffered from essential flaws limiting their scientific validity, including failure to spell it out the methodology used, or a lack of other basic information including, in some full cases, the results themselves! Which means that, in approving GM crops, protection regulators have relied almost on research conducted by the GMO companies themselves exclusively.